General Surgery Devices Market Size - By Product Type (Disposable Surgical Supplies, Open Surgery Instruments, Energy-based & Powered Instruments, Minimally Invasive Surgery Instruments, Medical Robotics & Computer Assisted Surgery Devices), By Application, By End-use, & Forecast, 2023 – 2032

General Surgery Devices Market Size

General Surgery Devices Market size was valued at around USD 17.2 billion in 2022 and is projected to reach over USD 34.9 billion by the end of 2032. This incremental growth rate is owing to increasing prevalence of chronic diseases coupled with rising demand for minimally invasive surgical procedures for the diagnosis and treatment of these ailments.
 

Technological advancements in general surgery devices associated with rising awareness regarding availability of high-precision surgical devices is anticipated to drive the market growth. General surgery devices are designed to aid in performing various surgical interventions, improving precision, reducing patient risks, and enhancing overall surgical outcomes.
 

The prevalence of chronic diseases like obesity, diabetes, and cardiovascular diseases has been on the rise. Additionally, growing preference for minimally invasive surgeries that involve smaller incisions, reduced scarring, and quicker recovery times has led to an increased demand for specialized surgical devices tailored for these procedures. Technological advancements have led to the development of more sophisticated and efficient surgical devices. These innovations have improved surgical procedures, resulting in better patient outcomes and shorter recovery times. Therefore, the general surgery devices industry is witnessing a growth trajectory due to technological advancements, aging population, and the rising incidence of chronic diseases thereby augmenting the product demand and fueling the market growth.
 

General surgery devices are medical instruments, equipment, and tools specifically designed and used by surgeons and medical professionals to perform various surgical procedures. These devices are tailored to meet the specific requirements of surgical procedures, ensuring precision, accuracy, and safety and can vary significantly in design and functionality.
 

However, high cost associated with advance general surgery devices can pose a significant challenge and impede the market growth in the coming years. High costs can limit access to advanced surgical devices for certain healthcare facilities, especially in lower-income regions or healthcare systems. For instance, the cost of surgical power tool device can range between USD 2,000 to USD 6,500 and can vary according to the technology and application.
 

Additionally, robotic surgical equipment can range around USD 1.5 million to USD 2.5 million. Hospitals and clinics with limited budgets may find it challenging to invest in expensive surgical equipment, leading to disparities in healthcare quality. Healthcare providers and institutions often have strict budget constraints, and the high upfront cost of purchasing advanced surgical devices can deter them from making such investments. The high capital investment required for equipment purchase, installation, maintenance, and regular upgrades can affect the financial viability of these providers. This financial burden limits the ability to expand their services, invest in new technologies, and offer competitive pricing.
 

 COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact that influenced the general surgery devices market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions impacted the market progress. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of orthopaedic, cardiology, ophthalmology, wound care and neurosurgery ailments among others. The COVID-19 pandemic reduced visits to healthcare facilities, causing medical services in several countries to be delayed, including minimally invasive procedures. The pandemic has disrupted global supply chains, causing delays in the production, delivery, and distribution of general surgery equipment’s.
 

During the pandemic, many healthcare systems faced significant strain due to the influx of COVID-19 patients. Factory closures, transportation restrictions, and shortages of raw materials impacted the availability of devices, leading to delays in fulfilling orders and potential price increases due to scarcity. With fewer surgeries being performed, there was less demand for general surgery devices, impacting market growth. To reduce the risk of virus transmission, there was an increased adoption of telemedicine and non-invasive treatment alternatives, that reduced the demand for certain surgical devices.
 

General Surgery Devices Market Trends

Increasing prevalence of chronic diseases is anticipated to drive the market trends. Chronic diseases are long-term health conditions that often require ongoing medical management, and surgical interventions play a crucial role in treating and managing these conditions. Chronic diseases, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, have become leading causes of morbidity and mortality worldwide. For instance, according to the World Health Organization data, in 2021, around 17.9 million people globally faced mortality due to cardiovascular disease. As the prevalence of these diseases continues to rise, there is a growing demand for surgical interventions to diagnose, treat, and manage these conditions effectively. With ongoing advancements in medical technology and surgical techniques, the management of chronic diseases has significantly improved.
 

Minimally invasive surgical procedures, robotic-assisted surgeries, and image-guided interventions have enhanced patient outcomes and reduced post-operative complications, driving the demand for general surgery devices globally. The aging population is more susceptible to chronic diseases leading to a higher demand for surgical interventions. Advancements in healthcare infrastructure in various regions have increased access to surgical interventions, making it possible for a larger population to seek treatment for chronic diseases. Manufacturers are engaged in developing and introducing innovative surgical devices to improve patient outcomes.
 

General Surgery Devices Market Analysis

Based on product type, the general surgery devices market is segmented as disposable surgical supplies, open surgery instruments, energy-based & powered instruments, minimally invasive surgery instruments, adhesion prevention products and medical robotics & computer assisted surgery devices. The disposable surgical supplies dominated the market accounting over 32% business share in 2022. Disposable surgical supplies are single-use medical devices and instruments that are used during surgical procedures. Disposable surgical supplies help reduce the risk of healthcare-associated infections by ensuring that each patient is treated with sterile, uncontaminated instruments. As hospitals and healthcare facilities focus on infection control measures, the demand for disposable supplies has increased significantly in the recent years.
 

Disposable supplies are pre-sterilized and ready to use, saving time for healthcare providers during surgical procedures. The convenience and ease of use contribute to the growing preference for disposable items in surgical settings. The use of disposable supplies reduces the risk of cross-contamination between patients that are suffering from drug-resistant infections. Additionally, the rising adoption of minimally invasive surgical procedures, such as laparoscopy and endoscopy, has led to an increased demand for specialized disposable surgical supplies that are designed for these techniques. Ongoing advancements in material science and manufacturing technology have led to the development of disposable surgical supplies that offer superior performance, biocompatibility, and safety.
 

Based on application, the general surgery devices market is segmented as orthopedic, cardiology, ophthalmology, wound care, neurosurgery, plastic surgery, urology and gynaecology surgery and others. The orthopedic segment accounted for around USD 3.6 billion in 2022. Orthopedic ailments refer to a range of musculoskeletal conditions affecting the bones, joints, ligaments, muscles, and tendons. As the population ages and lifestyles change, the prevalence of orthopedic conditions has been on the rise, leading to a higher demand for surgical interventions.
 

Increasing prevalence of orthopedic conditions, such as osteoarthritis, fractures, and degenerative joint diseases among ageing population has witnessed a significant rise in the recent years. For instance, according to the World Health Organization data, in 2020, over 528 million people worldwide were living with osteoarthritis accounting around 73% people aged 55 years and above. This rising prevalent population often necessitates the demand for minimally invasive surgical procedures incorporating general surgery devices for the diagnosis and treatment of orthopedic diseases.
 

Moreover, the prevalence of obesity is growing worldwide, and it is associated with an increased risk of orthopedic conditions, particularly osteoarthritis and joint pain. The growing popularity of minimally invasive orthopedic surgeries, such as arthroscopy, has increased the demand for general surgical instruments designed for these procedures. Increased awareness about orthopedic conditions and improved diagnostic techniques have led to earlier detection and treatment of musculoskeletal ailments, driving the demand for surgical interventions.
 

Based on end-use, the general surgery devices market is segmented as hospitals, ambulatory surgical centers, specialty clinics and others. The hospitals segment exceeded USD 9 billion in 2022. The increasing demand for general surgery devices in hospitals can be attributed to various factors, including advancements in medical technology, changes in surgical practices, rising patient expectations, and the need for improved patient outcomes. The rising population drives the demand for hospitals to cater to the healthcare needs of a larger number of people, consequently increasing the demand for general surgery devices used in hospital settings.
 

Hospitals continuously invest in advanced medical technologies to provide cutting-edge medical services to their patients. The adoption of innovative general surgery devices enhances surgical outcomes and patient care, driving the demand for these devices. Governments are investing in expanding healthcare infrastructure and promoting the development of hospitals to improve healthcare accessibility. The increasing prevalence of chronic diseases requires more extensive medical interventions and surgical procedures. Hospitals treating a higher number of patients with chronic ailments have a greater demand for general surgery devices.
 

North America general surgery devices market was valued at USD 7.2 billion in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from chronic diseases, an expanding elderly population, among others. North America has a well-established healthcare infrastructure, a strong emphasis on technological advancements, and a high burden of chronic diseases, that drives the demand for general surgery devices. The region experiences a high incidence of chronic diseases such as diabetes, obesity, and cardiovascular diseases. For instance, according to the CDC report, in 2022, around 130 million adults in the U.S. were suffering from diabetes and is expected to increase in the near future. These conditions often necessitate surgical treatments, spurring the demand for general surgery devices.
 

North America is at the forefront of medical technology and innovation. The continuous advancements in surgical techniques and medical devices lead to a higher adoption rate of advanced general surgery devices in the region. Minimally invasive surgical procedures are widely practiced in North America due to their benefits of shorter recovery times, reduced post-operative complications, and smaller incisions. The increasing popularity of these procedures drives the demand for general surgical devices.
 

General Surgery Devices Market Share

Some of the major players operating in the general surgery devices market are

• 3M
• B. Braun Melsungen Ag
• Becton
• Dickinson and Company
• Boston Scientific Corporation
• Cadence Inc
• Conmed Corporation
• Erbe Elektromedizin Gmbh
• Integer Holdings Corporation
• Integra LifeSciences
• Johnson & Johnson Service, Inc.
• Medtronic Plc
• Olympus Corporation
• Smith & Nephew
• Stryker Corporation
• CooperSurgical, Inc.
• Teleflex Incorporated

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

General Surgery Devices Market Leaders:

• In October 2022, Medtronic plc announced that they had received the regulatory approval from Europe, Canada, and Japan to market and commercialize their Hugo robotic-assisted surgery system in these regions. This system is intended for minimally invasive robotic-assisted surgical procedures. This strategic approval helped the company to enhance their customer base by entering into major geographic locations and increase the market presence.
   
• In September 2022, Olympus Corporation announced the launch of THUNDERBEAT Open Fine Jaw Type X, a surgical energy device for open surgery. This device delivers ultrasonic and bipolar energy simultaneously for tissue management, including hemostatic cutting and dissection, in laparoscopic surgery and open surgery. This innovative launch helped the company to enhance their product portfolio and increase their business revenue.
   

General surgery devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (Units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product Type, 2018 - 2032 (USD Million & Units)

• Disposable Surgical Supplies
  • Surgical Non-woven
  • Examination & Surgical Gloves
  • General Surgery Procedural Kits
  • Needles and Syringes
  • Venous Access Catheters
• Open Surgery Instruments
  • Retractor
  • Dilator
  • Catheters
• Energy-based & Powered Instruments
• Minimally Invasive Surgery Instruments
• Adhesion Prevention Products
• Medical Robotics & Computer Assisted Surgery Devices

By Application, 2018 - 2032 (USD Million)

• Orthopedic
• Cardiology
• Ophthalmology
• Wound Care
• Neurosurgery
• Plastic Surgery
• Urology and Gynaecology Surgery
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey